Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Dowling

Showing results (451-460 of 493) with videos related to

Pageof 50
Sort By:
Nature|May 24, 2023
Selective control of parasitic nematodes using bioactivated nematicidesAndrew R Burns, Rachel J Baker, Megan Kitner, et al.
Lancet (London, England)|July 10, 2022
Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trialPeter J Mitchell, Bernard Yan, Leonid Churilov, et al.
Nature Communications|July 24, 2021
Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survivalNathaniel D Anderson, Yael Babichev, Fabio Fuligni, et al.
Developmental Cognitive Neuroscience|August 4, 2024
The HEALthy Brain and Child Development Study (HBCD): NIH collaboration to understand the impacts of prenatal and early life experiences on brain developmentNora D Volkow, Joshua A Gordon, Diana W Bianchi, et al.
NPJ Vaccines|February 14, 2023
Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in miceEtsuro Nanishi, Francesco Borriello, Hyuk-Soo Seo, et al.
Journal of Child Neurology|March 21, 2012
Consensus statement on standard of care for congenital myopathiesChing H Wang, James J Dowling, Kathryn North, et al.
The Lancet. Neurology|November 17, 2023
Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trialPerry B Shieh, Nancy L Kuntz, James J Dowling, et al.
Nature Communications|December 3, 2025
Discovery of a small molecule TLR3 agonist adjuvantBranden Lee, Danica Dong, Etsuro Nanishi, et al.
Genome Medicine|July 2, 2025
Clinical applications of and molecular insights from RNA sequencing in a rare disease cohortJamie C Stark, Neta Pipko, Yijing Liang, et al.
Journal of Neuromuscular Diseases|June 13, 2022
INCEPTUS Natural History, Run-in Study for Gene Replacement Clinical Trial in X-Linked Myotubular MyopathyJames J Dowling, Wolfgang Müller-Felber, Barbara K Smith, et al.
Pageof 50

Showing results (451-460 of 493) with videos related to

Sort By:
Pageof 50
Nature|May 24, 2023
Selective control of parasitic nematodes using bioactivated nematicidesAndrew R Burns, Rachel J Baker, Megan Kitner, et al.
Lancet (London, England)|July 10, 2022
Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trialPeter J Mitchell, Bernard Yan, Leonid Churilov, et al.
Nature Communications|July 24, 2021
Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survivalNathaniel D Anderson, Yael Babichev, Fabio Fuligni, et al.
Developmental Cognitive Neuroscience|August 4, 2024
The HEALthy Brain and Child Development Study (HBCD): NIH collaboration to understand the impacts of prenatal and early life experiences on brain developmentNora D Volkow, Joshua A Gordon, Diana W Bianchi, et al.
NPJ Vaccines|February 14, 2023
Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in miceEtsuro Nanishi, Francesco Borriello, Hyuk-Soo Seo, et al.
Journal of Child Neurology|March 21, 2012
Consensus statement on standard of care for congenital myopathiesChing H Wang, James J Dowling, Kathryn North, et al.
The Lancet. Neurology|November 17, 2023
Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trialPerry B Shieh, Nancy L Kuntz, James J Dowling, et al.
Nature Communications|December 3, 2025
Discovery of a small molecule TLR3 agonist adjuvantBranden Lee, Danica Dong, Etsuro Nanishi, et al.
Genome Medicine|July 2, 2025
Clinical applications of and molecular insights from RNA sequencing in a rare disease cohortJamie C Stark, Neta Pipko, Yijing Liang, et al.
Journal of Neuromuscular Diseases|June 13, 2022
INCEPTUS Natural History, Run-in Study for Gene Replacement Clinical Trial in X-Linked Myotubular MyopathyJames J Dowling, Wolfgang Müller-Felber, Barbara K Smith, et al.
Pageof 50